Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain
Tomohiro Takano(National Institute of Infectious Diseases), Yoshimasa Takahashi(Hokkaido Pharmaceutical University)
Cited by 19
Related Papers
Protective neutralizing influenza antibody response in the absence of T follicular helper cells
|Nature Immunology|2016|141
Exposure of an occluded hemagglutinin epitope drives selection of a class of cross-protective influenza antibodies
|Nature Communications|2019|38